Section 19a-495-22-6 - Diversion(a) The multicare institution shall ensure authorized healthcare providers comply with the following requirements pursuant to 21 CFR 1301.72 for transferring, transporting or dispensing controlled substances as part of a mobile narcotic treatment program: (1) The authorized healthcare providers shall have control over all narcotic drugs in DEA schedules II to V, inclusive, when transferring them from the free-standing facility for the care or treatment of substance abusive or dependent persons to the mobile narcotic treatment vehicle, and when dispensing at the location;(2) Any narcotic drugs in DEA schedules II to V, inclusive, transferred to the mobile narcotic treatment vehicle shall be secured in the safe when not dispensing;(3) The mobile narcotic treatment vehicle shall return to the licensed multicare facility at the end of each day when the mobile narcotic treatment vehicle has finished providing services. The mobile narcotic treatment vehicle shall park at the existing registered location on file with the DEA and the Department. Authorized healthcare providers shall remove all narcotic drugs in DEA schedules II to V, inclusive, from the mobile narcotic treatment vehicle, secure such drugs in the facility and park the mobile narcotic treatment vehicle in a secure area; and(4) Approved mobile narcotic treatment programs may apply to the DEA for a waiver of the daily return requirement for DEA approval. The mobile narcotic treatment program shall notify the department of any waiver approved by the DEA.(b) Authorized healthcare providers shall not:(1) Receive controlled substances from other mobile narcotic treatment vehicles or any other entity;(2) Deliver controlled substances to other mobile narcotic treatment vehicles or any other entity; or(3) Conduct reverse distribution of controlled substances on a mobile narcotic treatment vehicle.(c) The Department of Consumer Protection shall be notified of any loss, theft, diversion, or robbery of controlled substances from the mobile narcotic treatment program.Conn. Agencies Regs. § 19a-495-22-6